Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 50% decrease from the number of companies inspected in the previous month, when six companies received six inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected period worked in the Biologics and Veterinary sectors.
There were two companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
B. Braun Medical, Inc. | Biologics | 08/06/2024 | No Action Indicated (NAI) |
Great Giant Foods USA, Inc. | Food and Cosmetics | 08/20/2024 | No Action Indicated (NAI) |
Veg-Land, Inc. | Food and Cosmetics | 08/28/2024 | Voluntary Action Indicated (VAI) |
Veg-Land, Inc. | Veterinary | 08/28/2024 | No Action Indicated (NAI) |